Topical L-Ascorbic Acid Formulation for a Better Management of Non-Melanoma Skin Cancer: Perspective for Treatment Strategies
Open Access
- 4 August 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (8) , 1201
Abstract
L-ascorbic acid, is a well-known molecule, sometimes used as antioxidant for skin care. Nonetheless, few studies have taken in account its utility as topical treatment for non-melanoma skin vancer. Non-melanoma skin cancer includes basal cell carcinoma and squamous cell carcinoma and is widespread worldwide with an increasing incidence. The purpose of this paper is to analyze the characteristics of L-ascorbic acid topical formulation, its percutaneous absorption and biochemical mechanism, focusing on its anti-cancer properties. In particular, it will be described how the pH and the concentration of the formulation are able to influence its distribution in the skin and tissues. We will report, the current knowledge on the pharmacokinetic aspects of L-ascorbic acid that allows us to reconsider it in the light of its ability to act as a prodrug and as an anticancer agent. Lastly, a short review with the aim to find any evidence of a possible clinical use of L-ascorbic acid for the treatment of non-melanoma skin cancer was made.Keywords
This publication has 30 references indexed in Scilit:
- Basal-Cell Carcinoma Incidence and Associated Risk Factors in US Women and MenAmerican Journal of Epidemiology, 2013
- Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic DiscoveriesAdvances in Nutrition, 2011
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences, 2007
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences, 2005
- External irradiation of epithelial skin cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metalsJournal of Biochemical and Biophysical Methods, 1988
- Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancerProceedings of the National Academy of Sciences, 1978
- Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proceedings of the National Academy of Sciences, 1976
- SOME PROPERTIES OF THE ASCORBATE FREE RADICAL*Annals of the New York Academy of Sciences, 1975
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974